Hydrogen inhalation alleviates nonalcoholic fatty liver disease in metabolic syndrome rats.
Boyan Liu, Junli Xue, Mengyu Zhang, Mingyue Wang, Tingting Ma, Min Zhao, Qianqian Gu, Shucun Qin · Molecular medicine reports · 2020
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, the present study revealed the dose-dependent effect of H₂ inhalation on the alleviation of liver lipid accumulation and 66% H₂ inhalation was found to significantly decrease hepatic cholesterol and triglycerides. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in rats. The present study revealed the dose-dependent effect of H₂ inhalation on the alleviation of liver lipid accumulation and 66% H₂ inhalation was found to significantly decrease hepatic cholesterol and triglycerides.
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 66% source-reported H₂ gas concentration; Source-reported hydrogen exposure: 66% source-reported H₂ gas concentration. The present study revealed the dose-dependent effect of H₂ inhalation on the alleviation of liver lipid accumulation and 66% H₂ inhalation was found to significantly decrease hepatic cholesterol and triglycerides. The authors concluded that in conclusion, hydrogen inhalation may play a protective role by influencing the general state, lipid metabolism parameters, liver histology and liver function indicators in the rat model of metabolic syndrome with NAFLD.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment. The hydrogen delivery method was hydrogen-rich water. The source-reported hydrogen concentration was 66% source-reported H₂ gas concentration.
Limitations and Safety
Reported limitations: However, the present study also has some limitations such as the lack of statistical significance for some factors and lack of detection of more genes associated with lipid metabolism.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.